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doi:10.1016/j.jmu.2010.11.002Miller-Dieker syndrome (MDS) is a contiguous gene deletion disorder involving genes on chro-
mosome 17p13.3. Clinical manifestations include central nervous system (CNS) anomalies
(mainly Type I lissencephaly), facial dysmorphism, growth restriction, profound mental retar-
dation, seizure, and extracranial anomalies. The affected individuals often die in infancy or
early childhood. Owing to the poor prognosis of MDS, early diagnosis of fetuses with MDS is
important. Currently, ultrasound is regarded as a useful tool in prenatal detection of MDS,
in addition to fetal magnetic resonance imaging. This article provides an overview of the
reported prenatal sonographic features of MDS, including CNS anomalies (ventriculomegaly,
agyria or lissencephaly, abnormal sylvian fissures, agenesis or dysgenesis of corpus callosum,
and microcephaly), intrauterine growth restriction, polyhydramnios, cardiac anomalies,
omphalocele, facial anomalies, and rare anomalies. Several diseases may have phenotypic
overlaps with MDS, including Type I lissencephaly (Lissencephaly 1, Lissencephaly 2, and
X-linked lissencephaly) and Type II lissencephaly. Increasing the awareness and knowledge
of fetal structural anomalies associated with MDS on prenatal ultrasound will be helpful in
the early detection, thus allowing appropriate genetic counseling and optimize clinical
management.
ª 2010, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Ping Chen, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2,
aiwan.
P. Chen).
C and the Chinese Taipei Society of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
148 C.-P. Chen, S.-C. ChienIntroduction
Miller-Dieker syndrome (MDS, OMIM 247200), described by
Miller [1] and Dieker et al [2], is a contiguous gene deletion
syndrome characterized by central nervous system (CNS)
anomalies, facial dysmorphism, growth restriction, profound
mental retardation, and extracranial anomalies. The CNS
anomalies include cerebral agyria or Type I lissencephaly,
ventriculomegaly, absent or hypoplastic corpus callosum,
and microcephaly. The facial features may present prom-
inent forehead with bitemporal narrowing, furrowed brow,
small nose with anteverted nostrils, low set ears, prominent
upper lip, and micrognathia. Seizure is often developed in
early childhood. Life expectancy is significantly shortened
and patients usually die during early childhood [3]. Associ-
ated extracranial anomalies may be present, such as cardiac
anomalies, omphalocele, and genitourinary anomalies [4,5].
The normal six-layered brain cortex is formed by
neuronal migration beginning at 8 weeks of gestation.
Impairment or arrest of neuronal migration at about 3e4
months of gestation can result in lissencephaly. On the basis
of clinicopathological classification, two types of lissence-
phaly have been proposed. Type I lissencephaly seen in MDS
is often associated with a microdeletion of chromosome
17p13.3. Three genes, LIS1 (PAFAH1B1; OMIM 601545), 14-3-
3e (YWHAE; OMIM 605066), and CRK (OMIM 164762), are
mapped to this locus [6,7]. Deletion or mutations in theseTable 1. Prenatal sonographic features of reported cases with
Cases Microdeletion CNS anomal
Ventriculom
Sermer et al [8] del(17p)
Greenberg et al [9] del(17)(p13)
Saltzman et al [10] del(17)(p13.3)mat
del(17)(p13.3)
Blass et al [11] del(17)(p13.2) (þ)
Okamura et al [12] () (þ)
() (þ)
Alvarado et al [13] del(17)(p13.3)pat
Holzgreve et al [14] () (þ)
McGahan et al [15] del(17)(p13.3) (þ)
Chitayat et al [5] del(17)(p13.3) (þ)
Greco et al [16] () (þ)
Fong et al [17] del(17)(p13.3) (þ)
del(17)(p13.3) (þ)
del(17)(p13.3)mat (þ)
del(17)(p13.3) (þ)
del(17)(p13.3)pat (þ)
del(17)(p13.3)
del(17)(p13.3) (þ)
Pastorino et al [18] () (þ)
Lenzini et al [19] del(17)(p13.3) (þ)
Herman and Siegel [20] distal 17p deletion
Aslan et al [21] ()
Lin et al [22] del(17)(p13.3) (þ)
Chen et al [23] del(17)(p13.2) (þ)
CNS Z central nervous system; IUFDZ intrauterine fetal death;
pregnancy.genes can cause the lissencephaly. Lissencephaly is also
present in several other diseases such as Norman-Roberts
syndrome and Walker-Warburg syndrome. Therefore,
differential diagnosis including Type I and Type II lissence-
phaly is discussed here.
Prenatal diagnosis is important due to the poor outcome
in MDS-affected cases. Magnetic resonance imaging is
considered to be a useful tool in the diagnosis of CNS
anomalies in fetuses of MDS. However, it is more expensive
and sedation of the fetus may be required during examina-
tion. At present, ultrasound is thought to be another possible
tool in the prenatal detection of characteristic findings
associated with MDS. To date, there have been approxi-
mately 25 reported cases of MDS having prenatal sonographic
findings. Here, we review the sonographic features in these
fetuses of MDS. Early diagnosis of MDS is significantly bene-
ficial for prenatal counseling and obstetric management.
Prenatal Sonographic Features
The prenatal sonographic features of published MDS cases
are summarized in Table 1 [5,8e23]. They include CNS
anomalies (ventriculomegaly, agyria or lissencephaly,
abnormal sylvian fissures, agenesis or dysgenesis of corpus
callosum, and microcephaly), intrauterine growth restric-
tion (IUGR), polyhydramnios, cardiac anomalies, omphalo-
cele, facial anomalies, and rare anomalies.Miller-Dieker Syndrome [8e23]
ies
egaly Lissencephaly
(agyria)
Abnormal
sylvian
fissure
Agenesis of
corpus callosum
(þ)
(þ)
(þ) (þ)
(þ) (þ)
(þ) (þ)
(þ)
(þ)
(þ) (þ)
(þ) (þ)
(þ)
(þ) (þ) (þ)
(þ) (þ)
(þ) (þ)
(þ) (þ)
(þ)
(þ) (þ)
(þ) (þ)
(þ)
IUGRZ intrauterine growth restriction; TOPZ termination of(continued)
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The CNS anomalies reported in fetuses of MDS include ven-
triculomegaly, agyria, abnormal sylvian fissures, agenesis or
dysgenesis of corpus callosum, and microcephaly. Ven-
triculomegaly is the most common finding in the reported
cases of MDS, and it has been shown to be an important
prenatal ultrasound marker for MDS [17,18,24]. Agyria or
smooth brain is the key feature of MDS. During the early
period, prenatal sonographic diagnosis of agyria and MDS is
rare as routine survey of fetal cerebral cortex is not included
in anatomic evaluation. Clinically, fetal cerebral sulci can
be demonstrated by sonography as early as 18 weeks’
gestation, and by 30e32 weeks, most of the main sulci can
be demonstrated [25e27]. However, ventriculomegaly may
obscure the visualization of the sulcal pattern because there
is a mean lag of 2 or more weeks in the development of sulci/
fissures in ventriculomegaly. Fong et al [17] reported that
mild ventriculomegaly could be the first sign of abnormal or
delayed brain maturation and suggested to carefully eval-
uate cerebral sulci at 24e26 weeks of gestation by sonog-
raphy, when a fetus had an apparently isolated mild
ventriculomegaly. In general, severe forms of lissencephaly,
such as complete agyria, are easily detected on prenatal
ultrasound, but milder forms of pachygyria and subcortical
band heterotopia (SBH) are difficult to diagnose. Agenesis orCNS anomalies IUGR Polyhydramnios Cardiac
anomalies
Omphalocele
Microcephaly
(þ) (þ)
(þ) (þ) (þ)
(þ) (þ)
(þ) (þ)
(þ) (þ)
(þ)
(þ) (þ)
(þ)
(þ)
(þ)
(þ)
(þ)
(þ)
(þ) (þ)
(þ) (þ) (þ)
(þ) (þ)
(þ)
(þ) (þ)
(þ) (þ)
CNS Z central nervous system; IUFDZ intrauterine fetal death;
pregnancy.
Table 1. (continued)dysgenesis of corpus callosum and microcephaly are also
observed in cases of MDS [11,19,21]. Lenzini et al [19]
reported that a fetus with a 4-Mb microdeletion at 17p13.3
had the prenatal sonographic findings of CNS anomalies,
including microcephaly, ventriculomegaly, dysgenetic
corpus callosum, hypoechoic cerebral parenchyma, and
pachygyria, at 29 weeks of gestation.
Intrauterine growth restriction
Intrauterine growth restriction (IUGR) is a common finding
associated with reported fetuses of MDS. They are associ-
ated with microdeletion of 17p13 (Table 1).
Polyhydramnios
Polyhydramnios is also a common feature associated with
fetuses of MDS (Table 1). It is usually detected beyond the
mid-second trimester.
Cardiac anomalies
The cardiac anomalies reported in fetuses of MDS include
tetralogy of Fallot (TOF), atrial septal defects (ASD),
ventricular septal defects (VSD), double-outlet rightFacial
anomalies
Rare
anomalies
Outcome
Neural tubal
defects
Thymic hypoplasia IUFD
Alive at delivery
TOP
(þ) Alive at delivery
Neonatal death
Neonatal death
TOP
Neonatal death
Alive at delivery
Alive with seizure at 4 m/o
Alive with seizure at 24 m/o
Died at 23 m/o
Neonatal death
IUFD
IUFD
Alive with seizure at 12 m/o
(þ) Died at 11 m/o
Died at 3 m/o
TOP
Equinovarus foot,
hyperechoic renal
parenchyma
IUFD
Alive at delivery
(þ) TOP
Alive with seizure at 10 m/o
Alive with seizure at 18 m/o
IUGRZ intrauterine growth restriction; TOPZ termination of
150 C.-P. Chen, S.-C. Chienventricle, and cardiomegaly. Saltzman et al [10] reported
a fetus of MDS with a deletion of 17p13.3 having TOF at 31
weeks’ gestation. Greenberg et al [9] reported a fetus with
a deletion of 17p13 having double-outlet right ventricle.
Chen et al [23] reported a fetus of congenital heart defect
with ASD, VSD, and TOF at 36 weeks of gestation in asso-
ciation with monosomy 17p (17p13.2/ pter). Sermer et al
[8] reported a case of 17p deletion associated with prena-
tally detected cardiomegaly.
Abdominal wall defect
Omphalocele can be a prenatal sonographic feature asso-
ciated with MDS [5,8,13,17]. Alvarado et al [13] reported
MDS and omphalocele in a family with multiple affected
offsprings with monosomy 17p (17p13.3/ pter) using
fluorescence in situ hybridization study. They concluded
that omphalocele should be one of the listed malformations
that make up the MDS.
Facial anomalies
Facial features in MDS may characterize prominent fore-
head with bitemporal narrowing, furrowed brow, a small
nose with anteverted nostrils, low set ears, prominent
upper lip, and micrognathia. However, not all of the
features can be easily detected on a prenatal ultrasound.
The prenatally reported facial anomalies associated with
MDS include micrognathia [11,17], hypotelorism [21], low-
set ears, and a small nose [11].
Rare anomalies
The reported rare anomalies in MDS include thymic hypo-
plasia, neural tubal defects, talipes eqinovarus, and
hyperechoic renal parenchyma. Greenberg et al [9] repor-
ted a case of 17p13 deletion associated with thymic hypo-
plasia. Sermer et al [8] reported a case of 17p deletion
associated with prenatally detected neural tubal defects.
Lenzini et al [19] reported that a fetus with a 4-Mb micro-
deletion at 17p13.3 had the prenatal sonographic findings
of talipes eqinovarus and hyperechoic renal parenchyma.
Molecular and Cytogenetic Diagnosis
MDS is often associated with microdeletion of chromosome
17p13.3. About 90% of MDS patients have visible or submi-
croscopic deletions of 17p13.3 [28]. Families with multiple
affected MDS children have been noted to have parental
balanced translocations between 17p and other chromo-
somal segments [4,29]. Familial chromosomal rearrange-
ment is reported in about 20% MDS patients [30]. Clinically,
an approach to laboratory diagnosis of MDS should include
traditional G-banded chromosome analysis to detect visible
deletions and translocations and then molecular diagnostic
tools such as DNA markers, fluorescence in situ hybridiza-
tion, or array-based comparative genomic hybridization to
identify submicroscopic deletions. If a deletion is found,
parental studies are required to determine whether the
deletion is de novo or inherited from a cryptictranslocation. Thus, genetic counseling about the recur-
rence risk can be accurately provided to the affected
families.
Differential Diagnosis
Lissencephaly is divided into two types. Classical or Type I
lissencephaly is characterized by an abnormally thick and
poorly organized four-layered cortex, enlarged ventricles,
and often hypoplasia of the corpus callosum. Type II or
cobblestone lissencephaly is characterized by a disorga-
nized unlayered cortex, overmigration of neurons into
the subpial space and gliovascular proliferation near the
surface of the cortex resulting in the formation of a gran-
ular surface, and effacement of gyri showing a bumpy
cobblestone-like appearance [31]. Owing to the lissence-
phaly commonly seen in MDS, differential diagnosis should
include Type I lissencephly (Lissencephaly 1, Lissence-
phaly 2, and X-linked lissencephaly) and Type II
lissencephaly.
Type I lissencephaly
Lissencephaly 1 (LIS 1; OMIM 607432)
LIS 1 includes isolated lissencephaly sequence, classic lis-
sencephaly, subcortical laminar heterotopia (SCLH), and
subcortical band heterotopia (SBH). It is characterized by
smooth or nearly smooth cerebral surface, encompassing
a spectrum of brain surface malformations ranging from
complete agyria to subcortical band heterotopia [32]. SBH
represents the less severe end of the LIS spectrum of mal-
formations [32]. LIS 1 caused by mutations in the PAFAH1B1
gene is also called “isolated” lissencephaly to distinguish it
from the accompanying features of MDS.
Lissencephaly 2 (LIS 2; OMIM 257320) or Norman-Roberts
syndrome
It is caused by mutations in the RFLN gene (OMIM 600514)
mapped to 7q22. It belongs to Type I lissencephaly with
distinctive features such as a low slopping forehead and
a prominent nasal bridge, which are not seen in MDS [33]. In
addition, it has been observed to have multiple affected
sibs and parental consanguinity.
X-linked lissencephaly
X-linked lissencephaly 1 (LISX1) includes lissencephaly and
agenesis of the corpus callosum, X-linked SCLH, X-linked
SBH, and double cortex syndrome. LISX1 can be caused by
mutations in the DCX gene (OMIM 300121) mapped to
Xq22.3-q23. Male patients generally have a more severe
phenotype compared to females. The gyral patterns are
different in LIS 1 and LISX1. Those with PAFAH1B1 muta-
tions are associated with more severe malformations pos-
teriorly, and those with DCX mutations are associated with
more severe malformation anteriorly. In addition, hypo-
plasia of the cerebellar vermis was more common in LISX1
[32]. X-linked lissencephaly 2 (LISX2) includes X-linked
lissencephaly with ambiguous genitalia and hydranence-
phaly and abnormal genitalia, and can be caused by
mutations in the ARX gene (OMIM 300382) mapped to
Xq22.13.
Table 2. Prenatal sonographic features of Miller-Dieker Syndrome and differential diagnosis
Prenatal sonographic features
Central nervous system anomalies
Ventriculomegaly, agyria or lissencephaly, abnormal sylvian fissures, agenesis or dysgenesis of corpus
callosum, microcephaly
Intrauterine growth restriction
Polyhydramnios
Cardiac anomalies
Tetralogy of Fallot, atrial septal defects, ventricular septal defects, double-outlet right ventricle, cardiomegaly
Abdominal wall defect
Omphalocele
Facial anomaly
Micrognathia, hypotelorism, low-set ears, a small nose
Rare anomalies
Thymic hypoplasia, neural tubal defects, talipes eqinovarus, hyperechoic renal parenchyma
Differential diagnosis
Type I lissencephaly
Lissencephaly 1
Lissencephaly 2 (Norman-Roberts syndrome)
X-linked lissencephaly
Type II lissencephaly
Walker-Warburg syndrome
Fukuyama-type congenital muscular dystrophy
Muscle-eye-brain disease and muscular dystrophy
Muscular dystrophy, congenital, Type IC
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Type II lissencephaly occurs with four prototypic autosomal
recessive disorders: Walker-Warburg syndrome (WWS, OMIM
236670), Fukuyama-type congenital muscular dystrophy
(OMIM 253800), muscle-eye-brain disease (OMIM 253280),
and muscular dystrophy, congenital, Type IC (MDC1C, OMIM
606612) [24,31]. WWS or HARD E syndrome is character-
ized by hydrocephalus (H), agyria (A), retinal dysplasia (RD)
with or without encephalocele (E), and congenital
muscular dystrophy. CNS anomalies associated with WWS
include Type II lissencephaly (100%), cerebellar malforma-
tion (100%), ventriculomegaly (95%), Dandy-Walker mal-
formation (53%), and occipital encephalocele (24%) [34].
WWS can be caused by mutations in these genes, including
POMT1 (OMIM 607423), FKTN (OMIM 607440), FKRP (OMIM
606596), POMT2 (OMIM 607439), and LARGE (OMIM 603590).
Fukuyama-type congenital muscular dystrophy has an
overlapping phenotype with mild WWS and is caused by
mutations in the FKTN gene. Muscle-eye-brain disease also
has phenotypic similarities with WWS and can be caused by
mutations in the FKRP gene and the POMGNT1 gene (OMIM
606822). MDC1C is characterized by muscle weakness and
structural brain defects and can be caused by mutations in
the FKRP gene. All the above diseases may present with
more severe lissencephaly, marked ventriculomegaly, and
hydrocephalus. One fetus has been diagnosed with WWS as
early as 18 weeks because of the marked ventriculomegaly
[35]. Therefore, Type II lissencephaly may be more easily
detected in prenatal period than Type I because of the
marked ventriculomegaly.Conclusion
This article provides an overview of prenatal sonographic
features of MDS. Prenatal detection of CNS anomalies (ven-
triculomegaly, agyria or lissencephaly, abnormal sylvian
fissures, agenesis or dysgenesis of corpus callosum, and
microcephaly), IUGR, polyhydramnios, cardiac anomalies,
omphalocele, facial anomalies, and rare anomalies should
alert clinicians to the possibility of MDS and prompt molec-
ular cytogenetic analyses and counseling for MDS (Table 2).
Differential diagnosis should include Type I lissencephaly
(Lissencephaly 1, Lissencephaly 2, X-linked lissencephaly)
and Type II lissencephaly (Table 2). Early diagnosis of MDS is
important because of extremely poor prognosis in affected
cases. Prenatal diagnosis of MDS is helpful for accurate
genetic counseling and appropriate obstetric management.
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